PHASEBIO PHARMACEUTICALS INC

CUSIP: 717224109 Class: COM

DAFNA Capital Management LLC's Holding History (CIK: 0001389933)

Note: Option positions (PUT/CALL) are excluded.

Q4 2022
Shares 321,856 Value ($000) $10 Avg Close — Range —
Q3 2022
Shares 321,856 Value ($000) $57 Avg Close — Range —
Q2 2022
Shares 378,611 Value ($000) $227 Avg Close — Range —
Q1 2022
Shares 378,611 Value ($000) $500 Avg Close — Range —
Q4 2021
Shares 378,611 Value ($000) $988 Avg Close — Range —
Q3 2021
Shares 603,042 Value ($000) $1,875 Avg Close — Range —
Q2 2021
Shares 603,042 Value ($000) $2,243 Avg Close — Range —
Q1 2021
Shares 603,042 Value ($000) $2,087 Avg Close — Range —
Q4 2020
Shares 320,542 Value ($000) $1,077 Avg Close — Range —
Q3 2020
Shares 320,542 Value ($000) $1,125 Avg Close — Range —
Q2 2020
Shares 320,542 Value ($000) $1,474 Avg Close — Range —
Q1 2020
Shares 320,542 Value ($000) $1,061 Avg Close — Range —
Q4 2019
Shares 360,542 Value ($000) $2,203 Avg Close — Range —
Q3 2019
Shares 360,542 Value ($000) $1,503 Avg Close — Range —
Q2 2019
Shares 200,013 Value ($000) $2,624 Avg Close — Range —
Q1 2019
Shares 72,500 Value ($000) $689 Avg Close — Range —
Q4 2018
Shares 100,000 Value ($000) $309 Avg Close — Range —